awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26751237-62EA7864-738C-47BF-BC80-BCE65C7181F5
Q26751237-62EA7864-738C-47BF-BC80-BCE65C7181F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26751237-62EA7864-738C-47BF-BC80-BCE65C7181F5
Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer
P2860
Q26751237-62EA7864-738C-47BF-BC80-BCE65C7181F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26751237-62EA7864-738C-47BF-BC80-BCE65C7181F5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5864e62a0dc127baa50ef718a775b2aed539b6a1
P2860
Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone.